Literature DB >> 20461756

Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma.

Marjolijn C J Jongmans1, Peter M Hoogerbrugge, Linda Hilkens, Uta Flucke, Ineke van der Burgt, Kees Noordam, Martina Ruiterkamp-Versteeg, Helger G Yntema, Willy M Nillesen, Marjolijn J L Ligtenberg, Ad Geurts van Kessel, Roland P Kuiper, Nicoline Hoogerbrugge.   

Abstract

Noonan Syndrome (NS) is an autosomal dominant condition characterized by short stature, facial dysmorphisms, and congenital heart defects, and is caused by mutations in either PTPN11, KRAS, NRAS, SHOC2, RAF1, or SOS1. Furthermore, NS is known for its predisposition to develop cancer, particularly hematological malignancies and specific solid tumors, mainly neuroblastoma and embryonal rhabdomyosacroma (ERMS). Until recently, however, cancer predisposition in NS patients with SOS1 mutations was not reported. Here we present a NS patient with a de novo germline SOS1 mutation (p.Lys728Ile) and ERMS. This heterozygous germline mutation was homozygously present in the ERMS of this patient due to an acquired uniparental disomy (UPD) of chromosome 2. In addition, several other chromosomal aberrations were encountered, some of which are known to recurrently occur in ERMS. Sequence analysis of the SOS1 gene in 20 sporadic ERMS tumors failed to reveal any pathogenic mutations, implicating that SOS1 is not a major player in the development of this tumor outside the context of NS. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461756     DOI: 10.1002/gcc.20773

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

1.  Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.

Authors:  Yoko Aoki; Tetsuya Niihori; Toshihiro Banjo; Nobuhiko Okamoto; Seiji Mizuno; Kenji Kurosawa; Tsutomu Ogata; Fumio Takada; Michihiro Yano; Toru Ando; Tadataka Hoshika; Christopher Barnett; Hirofumi Ohashi; Hiroshi Kawame; Tomonobu Hasegawa; Takahiro Okutani; Tatsuo Nagashima; Satoshi Hasegawa; Ryo Funayama; Takeshi Nagashima; Keiko Nakayama; Shin-Ichi Inoue; Yusuke Watanabe; Toshihiko Ogura; Yoichi Matsubara
Journal:  Am J Hum Genet       Date:  2013-06-20       Impact factor: 11.025

2.  New Genetic Insights into Congenital Heart Disease.

Authors:  Stephanie M Ware; John Lynn Jefferies
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

3.  Noonan syndrome: comparing mutation-positive with mutation-negative dutch patients.

Authors:  E A Croonen; W Nillesen; C Schrander; M Jongmans; H Scheffer; C Noordam; J M T Draaisma; I van der Burgt; H G Yntema
Journal:  Mol Syndromol       Date:  2013-05-08

Review 4.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

5.  Mammalian son of sevenless Guanine nucleotide exchange factors: old concepts and new perspectives.

Authors:  José M Rojas; José Luis Oliva; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

6.  A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.

Authors:  Adepitan A Owosho; Shih-Chiang Huang; Sonja Chen; Shruti Kashikar; Cherry L Estilo; Suzanne L Wolden; Leonard H Wexler; Joseph M Huryn; Cristina R Antonescu
Journal:  Oral Oncol       Date:  2016-09-06       Impact factor: 5.337

7.  SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations.

Authors:  Francesca Lepri; Alessandro De Luca; Lorenzo Stella; Cesare Rossi; Giuseppina Baldassarre; Francesca Pantaleoni; Viviana Cordeddu; Bradley J Williams; Maria L Dentici; Viviana Caputo; Serenella Venanzi; Michela Bonaguro; Ines Kavamura; Maria F Faienza; Alba Pilotta; Franco Stanzial; Francesca Faravelli; Orazio Gabrielli; Bruno Marino; Giovanni Neri; Margherita Cirillo Silengo; Giovanni B Ferrero; Isabella Torrrente; Angelo Selicorni; Laura Mazzanti; Maria C Digilio; Giuseppe Zampino; Bruno Dallapiccola; Bruce D Gelb; Marco Tartaglia
Journal:  Hum Mutat       Date:  2011-04-28       Impact factor: 4.878

8.  Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

Authors:  Marjolijn C J Jongmans; Ineke van der Burgt; Peter M Hoogerbrugge; Kees Noordam; Helger G Yntema; Willy M Nillesen; Roland P Kuiper; Marjolijn J L Ligtenberg; Ad Geurts van Kessel; J Han J M van Krieken; Lambertus A L M Kiemeney; Nicoline Hoogerbrugge
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

Review 9.  Germline predisposition to genitourinary rhabdomyosarcoma.

Authors:  Kami Wolfe Schneider; Nicholas G Cost; Kris Ann P Schultz; Shayna Svihovec; Alexandra Suttman
Journal:  Transl Androl Urol       Date:  2020-10

Review 10.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.